Endolytix
Boston, United States · $9.3M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- endolytx.bio
- Total Funding
- $9.3M
- Last Round
- Growth EquityOct 2024
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
Biotech company developing novel therapeutics to treat antibiotic-resistant infections, with a focus on non-tuberculous mycobacterial (NTM) disease.
Summary
Endolytix is a Biotech company based in Boston, United States. It has raised $9.3M in total across 3 rounds, most recently a Growth Equity round in Oct 2024. Investors include Morningside Group and Kineticos AMR Accelerator Fund I.
Funding History
Oct 2024
Sign up to see all 3 events
Funding: Seed through Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/endolytix"><img src="https://indexed.vc/api/badge/company/endolytix" alt="Endolytix on Indexed.vc" width="260" height="76" /></a>